Eastman Chemical vs Westlake
Add, change or remove companies; up to four.
KIRA’s take AI analyst
I put Eastman Chemical and Westlake side by side, using each one’s latest annual report. Here is what stands out:
- Westlake is the larger business, with $11.2B of revenue in fiscal 2025 against $8.8B for Eastman Chemical.
- Eastman Chemical grew revenue faster (−6.7%, against −8.0%).
- Eastman Chemical turned more of its sales into free cash flow (4.8% FCF margin, against −4.7%).
- Eastman Chemical earned a higher return on the capital invested in it (6.5%, against −10.0%).
Who comes out ahead
Of the 9 measures where higher (or lower) is clearly better, how many each company leads.
Eastman Chemical
EMN
8/9
Revenue growthGross marginNet marginFCF marginReturn on capitalReturn on equityPiotroski F-scoreShare count change
Westlake
WLK
1/9
5-year growth
Side by side
Best in the row
| Latest fiscal year | EMN FY25 | WLK FY25 |
|---|---|---|
| Size | ||
| Market cap | $7.6B | $8.4B |
| Revenue | $8.8B | $11.2B |
| Free cash flow | $424M | −$530M |
| Net income | $474M | −$1.5B |
| Growth | ||
| Revenue growth | −6.7% | −8.0% |
| 5-year growth | 0.7% | 8.3% |
| Share count change | −2.0% | −0.7% |
| Profitability | ||
| Gross margin | 21.1% | 7.3% |
| Operating margin | — | −14.1% |
| Net margin | 5.4% | −13.5% |
| FCF margin | 4.8% | −4.7% |
| Return on capital | 6.5% | −10.0% |
| Return on equity | 8.1% | −15.6% |
| Balance sheet | ||
| Net debt | $4.2B | $2.9B |
| Net debt / EBITDA | 3.3x | — |
| Dividends and buybacks | $381M | $335M |
| Valuation & quality | ||
| P/E | 17.1x | — |
| Piotroski F-score | 5 | 3 |
Ten years
Revenue
Operating margin
Free cash flow
Return on capital
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.